ArticleInternational immunopharmacology2021

Type 2 diabetes mellitus impaired nasal immunity and increased the risk of hyposmia in COVID-19 mild pneumonia patients.

Yi Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.